168 related articles for article (PubMed ID: 38123542)
1. TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer.
Zhang R; Shen Y; Zhang Q; Feng X; Liu X; Huo X; Sun J; Hao J
Cell Death Dis; 2023 Dec; 14(12):850. PubMed ID: 38123542
[TBL] [Abstract][Full Text] [Related]
2. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
3. OTUD5-mediated deubiquitination of YAP in macrophage promotes M2 phenotype polarization and favors triple-negative breast cancer progression.
Zhang Y; Fan Y; Jing X; Zhao L; Liu T; Wang L; Zhang L; Gu S; Zhao X; Teng Y
Cancer Lett; 2021 Apr; 504():104-115. PubMed ID: 33587979
[TBL] [Abstract][Full Text] [Related]
4. Honokiol prevents lung metastasis of triple-negative breast cancer by regulating polarization and recruitment of macrophages.
Mei M; Tang L; Zhou H; Xue N; Li M
Eur J Pharmacol; 2023 Nov; 959():176076. PubMed ID: 37797675
[TBL] [Abstract][Full Text] [Related]
5. G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression.
Li Y; Han X; Lin Z; Wang C; Fu Z; Sun Q; Li C
Cell Mol Life Sci; 2023 May; 80(6):165. PubMed ID: 37237244
[TBL] [Abstract][Full Text] [Related]
6. The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development.
Zhang C; Wei S; Dai S; Li X; Wang H; Zhang H; Sun G; Shan B; Zhao L
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37217247
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling.
Chen X; Yang M; Yin J; Li P; Zeng S; Zheng G; He Z; Liu H; Wang Q; Zhang F; Chen D
Cell Commun Signal; 2022 Jun; 20(1):92. PubMed ID: 35715860
[TBL] [Abstract][Full Text] [Related]
8. Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness.
Pe KCS; Saetung R; Yodsurang V; Chaotham C; Suppipat K; Chanvorachote P; Tawinwung S
PLoS One; 2022; 17(8):e0273044. PubMed ID: 35960749
[TBL] [Abstract][Full Text] [Related]
9. Sphingomyelin synthase 2 facilitates M2-like macrophage polarization and tumor progression in a mouse model of triple-negative breast cancer.
Deng Y; Hu JC; He SH; Lou B; Ding TB; Yang JT; Mo MG; Ye DY; Zhou L; Jiang XC; Yu K; Dong JB
Acta Pharmacol Sin; 2021 Jan; 42(1):149-159. PubMed ID: 32451413
[TBL] [Abstract][Full Text] [Related]
10. The Immunosuppressive Microenvironment in BRCA1-IRIS-Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated Macrophages.
Sami E; Paul BT; Koziol JA; ElShamy WM
Cancer Res; 2020 Mar; 80(5):1102-1117. PubMed ID: 31911557
[TBL] [Abstract][Full Text] [Related]
11. AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage.
Pei JP; Wang Y; Ma LP; Wang X; Liu L; Zhang Y; Jin R; Ren ZQ; Deng Y; Shen JK; Meng T; Yu K
Acta Pharmacol Sin; 2023 Jun; 44(6):1290-1303. PubMed ID: 36650292
[TBL] [Abstract][Full Text] [Related]
12. SILAC proteomics based on 3D cell spheroids unveils the role of RAC2 in regulating the crosstalk between triple-negative breast cancer cells and tumor-associated macrophages.
Guo Y; Deng X; Wang S; Yuan Y; Guo Z; Hao H; Jiao Y; Li P; Han S
Int J Biol Macromol; 2024 Jan; 254(Pt 1):127639. PubMed ID: 37879580
[TBL] [Abstract][Full Text] [Related]
13. Ruyiping extract reduces lung metastasis in triple negative breast cancer by regulating macrophage polarization.
Yang R; Xie Y; Li Q; Ye Y; Shi Y; Zhao X; Wu C; Xu Y; Wang R; Zhang Y; Yang X; Han X; Liu S
Biomed Pharmacother; 2021 Sep; 141():111883. PubMed ID: 34246955
[TBL] [Abstract][Full Text] [Related]
14. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
[TBL] [Abstract][Full Text] [Related]
15. Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress.
Al Haq AT; Tseng HY; Chen LM; Wang CC; Hsu HL
Cell Death Dis; 2022 Jan; 13(1):49. PubMed ID: 35017469
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer.
Kim S; Choi I; Han IH; Bae H
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555393
[TBL] [Abstract][Full Text] [Related]
17. VEGFA/NRP-1/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk.
Wang L; Zhang L; Zhao L; Shao S; Ning Q; Jing X; Zhang Y; Zhao F; Liu X; Gu S; Zhao X; Luo M
Int J Biol Sci; 2024; 20(2):446-463. PubMed ID: 38169627
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-Derived Adenosine Deaminase 2 Correlates with M2 Macrophage Phenotype in Triple Negative Breast Cancer.
Kutryb-Zajac B; Harasim G; Jedrzejewska A; Krol O; Braczko A; Jablonska P; Mierzejewska P; Zielinski J; Slominska EM; Smolenski RT
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916440
[TBL] [Abstract][Full Text] [Related]
19. miR-149 Suppresses Breast Cancer Metastasis by Blocking Paracrine Interactions with Macrophages.
Sánchez-González I; Bobien A; Molnar C; Schmid S; Strotbek M; Boerries M; Busch H; Olayioye MA
Cancer Res; 2020 Mar; 80(6):1330-1341. PubMed ID: 31911555
[TBL] [Abstract][Full Text] [Related]
20. Oligo-Fucoidan supplementation enhances the effect of Olaparib on preventing metastasis and recurrence of triple-negative breast cancer in mice.
Chen LM; Yang PP; Al Haq AT; Hwang PA; Lai YC; Weng YS; Chen MA; Hsu HL
J Biomed Sci; 2022 Sep; 29(1):70. PubMed ID: 36109724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
